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Abstract
 
CD8
 
 
 
 T cells play a central role in the resolution and containment of viral infections. A key
effector function of CD8
 
 
 
 T cells is their cytolytic activity toward infected cells. Here, we studied
the regulation of cytolytic activity in naive, effector, and central versus effector memory CD8
 
 
 
T cells specific for the same glycoprotein-derived epitope of lymphocytic choriomeningitis virus.
Our results show that the kinetics of degranulation, assessed by a novel flow cytometric based
assay, were identical in effector and both subsets of memory CD8
 
 
 
 T cells, but absent in naive
CD8
 
 
 
 T cells. However, immediate cytolytic activity was most pronounced in effector T cells,
low in effector memory T cells, and absent in central memory T cells, correlating with the
respective levels of cytolytic effector molecules present in lytic granules. These results indicate
that an inherent program of degranulation is a feature of antigen-experienced cells as opposed to
naive CD8
 
 
 
 T cells and that the ability of CD8
 
 
 
 T cells to induce target cell apoptosis/death is
dependent on granule protein content rather than on the act of degranulation itself. Further-
more, these results provide a potential mechanism by which central memory CD8
 
 
 
 T cell–
mediated death of antigen-presenting cells within the lymph node is avoided.
Key words: cytotoxic T cell • central memory • effector memory • lytic granules • virus
 
Introduction
 
CD8
 
 
 
 T lymphocytes recognize, via their TCR, processed
peptides usually originating from intracellular proteins that
are presented on the cell surface bound to MHC class I
molecules. Activation of naive CD8
 
 
 
 T cells in secondary
lymphoid organs induces a developmental program that
leads to proliferation and differentiation into effector and
memory cells (1, 2). Effector CD8
 
 
 
 T cells exhibit direct
ex vivo effector function, such as cytotoxicity and cytokine
production, upon TCR engagement (3, 4). Memory
CD8
 
 
 
 T cells exhibit only minimal ex vivo cytolytic activity
if compared with effector cells but are able to produce cy-
tokines with equivalent kinetics to effector CD8
 
 
 
 T cells
(3, 4). Two subsets of memory CD8
 
 
 
 T cells have been
described according to their recirculation pattern (5, 6) as
follows: (a) central memory T cells that express lymph
node homing markers, such as CCR7 and CD62L, and
preferentially reside in secondary lymphoid organs, and (b)
effector memory T cells devoid of LN homing markers and
preferentially localized in peripheral tissue. Both subsets of
memory cells can be found in the blood and in the spleen.
Central and effector memory CD8
 
 
 
 T cells have initially
been described to have different kinetics in acquisition of
effector functions (5, 7). However, several recent analyses
have shown that purified central and effector CD8
 
 
 
 T cells
exhibit only minimal differences in their ability to exert
immediate effector functions, such as cytotoxicity and cy-
tokine production (4, 8, 9).
Cytolytic activity mediated by CD8
 
 
 
 T cells is crucial for
the resolution/containment of viral infections, in particular
for infections with noncytopathic viruses (10, 11). CD8
 
 
 
 T
cells mediate cytolytic activity against target cells via two
major pathways: the granule exocytosis pathway, involving
the directed release of granule contents such as perforin and
granzymes toward the target cell, and a granule-independent
pathway involving the ligation of death receptors on the
target cell (e.g., fas/fasL interaction; for review see reference
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12). The granule-dependent pathway does not require de
novo synthesis of effector molecules, but relies on the pres-
ence of stored effector molecules in lytic granules (for re-
view see reference 13). Lytic granules are membrane-bound
secretory lysosomes containing a dense core of various ef-
fector molecules (perforin and granzymes). The membrane
of lytic granules contains lysosomal-associated glycoproteins
(LAMPs) such as CD107a (LAMP-1), CD107b (LAMP-2),
and CD63 (LAMP-3; reference 14). These glycoproteins
are usually not expressed on the plasma membrane of T
lymphocytes, but cell surface expression has been observed
after activation of T cells with PHA or ionomycin (15, 16).
It has been shown recently that antigen-specific activation
of human peripheral CD8
 
 
 
 T lymphocytes leads to cell sur-
face expression of CD107a and CD107b, which can be fol-
lowed by flow cytometric analysis (17). Cell surface expres-
sion of CD107a and -b occurred rapidly after antigen
encounter, was associated with release of lytic granule pro-
teins (perforin and granzyme B [grB]), and was inhibited by
the microtubule inhibitor colchicine, indicating that anti-
gen-induced expression of CD107a and -b was identifying
T cells that had degranulated and released effector proteins
from their lytic granules (17). Furthermore, it was shown in
mice that activation of CD8
 
 
 
 T cells leads to up-regulation
of CD107 on the cell surface (18).
Based on this novel assay, we analyzed the kinetics of de-
granulation, release, and production of effector proteins
and cytolytic potential in defined populations of murine vi-
rus-specific CD8
 
 
 
 T cells. These populations included na-
ive TCR transgenic CD8
 
 
 
 T cells specific for the lympho-
cytic choriomeningitis virus (LCMV) GP peptide epitope
gp33–41, effector CD8
 
 
 
 T cells from acutely LCMV-
infected mice, and central and effector memory CD8
 
 
 
 T
cells with the same antigen specificity.
 
Materials and Methods
 
Mice.
 
Transgenic mice expressing a TCR specific for LCMV
peptide gp33-41 (P14 tg) presented in association with H2-D
 
b
 
 and
transgenic mice expressing a TCR specific for LCMV peptide gp64-
80 (Smarta tg) have been described previously (19, 20). C57BL/6
(B6) mice were purchased from Harlan and kept under specific
pathogen-free conditions. Animal experiments were performed ac-
cording to the regulations of the cantonal veterinary office.
 
Virus and Peptides.
 
The LCMV isolate WE was provided by
R.M. Zinkernagel (University Hospital, Zürich, Switzerland)
and was propagated on L929 fibroblast cells at low multiplicity of
infection. Mice were infected i.v. with 200 PFU LCMV-WE.
The LCMV glycoprotein peptides amino acids 33-41 (gp33
peptide, KAVYNFATM) and 64-80 (gp64 peptide, GPDIYKG-
VYQFKSVEFD) were purchased from Neosystem.
 
Antibodies and Peptide MHC Class I Tetramers.
 
Allophycocya-
nin (APC)- or PE-conjugated peptide–MHC class I tetrameric
complexes were generated as described previously (21). The fol-
lowing anti–mouse monoclonal antibodies and APC-conjugated
streptavidin were purchased from BD Biosciences: anti-CD107a
(FITC), anti-IFN
 
 
 
 (FITC, PE, or APC), anti-CD8 (peridinin
chlorophyll protein), anti-CD4 (peridinin chlorophyll protein),
anti-CD49d (biotin), and anti-CD62L (APC). Staining for grB
was performed using PE-labeled anti–human grB (Caltag). The
specificity of this reagent for mouse grB has been confirmed
previously (4).
 
Cell Stimulation.
 
Spleen cells were stimulated in vitro with 1
 
 
 
g/ml gp33 peptide in 1 ml RPMI 1640 medium containing
10% FCS and penicillin/streptomycin. FITC-conjugated anti–
mouse CD107a and Monensin A (Sigma-Aldrich) was added to
the cells during the stimulation period. In every experiment, a
negative control (no addition of peptide) was included to control
for spontaneous production of cytokine and/or CD107a expres-
sion. In some experiments, cycloheximide (Sigma-Aldrich) was
present at 20 
 
 
 
g/ml for the duration of stimulation.
 
Immunofluorescent Staining and Analysis.
 
After the indicated
stimulation periods, cells were washed once and surface stained at
4
 
 
 
C with directly labeled antibodies, peptide MHC class I tetra-
mers, or primary biotinylated antibodies, followed by washing and
incubation with APC-conjugated streptavidin. Cells were washed
once and fixed/permeabilized using 500 
 
 
 
l of FIX/perm solution
(FACSLyse™ [BD Biosciences] diluted to 2
 
 
 
 concentration with
H
 
2
 
0 and 0.05% Tween 20 [Sigma-Aldrich]). Cells were washed
once and incubated at room temperature with directly conjugated
antibodies specific for intracellular proteins. Cells were washed
and resuspended in PBS containing 1% paraformaldehyde (Sigma-
Aldrich). Four-color flow cytometric analysis was performed
using a FACSCalibur™ flow cytometer (BD Biosciences) with
CELLQuest™ software (BD Biosciences). List mode data were
analyzed using WinList software (Verity Software House, Inc.). In
all cases, at least 100,000 events were collected for analysis.
 
Isolation of T Cell Subsets.
 
CD62L positive and CD62L nega-
tive lymphocytes were purified using anti-CD62L magnetic
beads (Miltenyi Biotec) according to the manufacturer’s instruc-
tions. The purity of samples ranged from 91 to 96% for CD62L
negative cells and from 83 to 95% for CD62L positive cells.
 
Direct Ex Vivo Cytotoxicity Assay.
 
51
 
Cr release assays were
used for the determination of LCMV-gp33–specific cytotoxicity
ex vivo on EL4 target cells as described previously (22). In all
cases, the starting E/T ratio was adjusted to obtain identical ratios
of D
 
b
 
-gp33–specific CD8
 
 
 
 T cells to target cells. Spontaneous re-
lease was 
 
 
 
25% in all assays shown.
 
In Vivo Cytotoxicity Assay.
 
Splenocytes and LN cells from na-
ive B6 mice were costained with PKH26 (Sigma-Aldrich) and ei-
ther 5 
 
 
 
M or 0.5 
 
 
 
M carboxyfluorescein diacetate succinimidyl
ester (CFSE; Molecular Probes) according to the manufacturer’s
instructions. The labeled cells were pulsed with 10
 
 
 
6
 
 M gp33 pep-
tide for 1 h at 37
 
 
 
C or incubated in medium, washed three times
with PBS, mixed at equal amounts, and a total of 10
 
7
 
 cells were
adoptively transfused i.v. into acutely LCMV-infected mice, into
LCMV memory mice, or into naive control recipients. At the in-
dicated time points, lymphocytes were isolated from the blood,
spleen, and LN. Target cells were distinguished from recipient cells
by gating on PKH26 positive cells. Gp33-loaded and unloaded tar-
get cells were distinguished according to the CFSE fluorescence
intensity. The percentage of specific target cell elimination was cal-
culated as follows: 100 
 
 
 
 [(% peptide pulsed in infected recipients/%
unpulsed in infected recipients)/(% peptide pulsed in uninfected
recipients/% unpulsed in uninfected recipients)] 
 
 
 
 100.
 
Results
 
Rapid Degranulation of Effector and Memory CD8
 
 
 
 T Cells
after Antigen Encounter.
 
To compare the capacity of anti-
gen-specific naive, effector, and memory CD8
 
 
 
 T cells to 
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degranulate upon antigen encounter, we used either naive
TCR transgenic (P14 tg, specific for LCMV gp33-41) CD8
 
 
 
T cells or CD8
 
 
 
 T cells from acutely infected C57BL/6 mice
(day 8, 200 PFU of LCMV WE) or from memory mice (day
50, 200 PFU of LCMV WE). To examine the kinetics of ac-
tivation of LCMV gp33-specific CD8
 
 
 
 T cells, we measured
cytokine production (IFN
 
 
 
) and degranulation by cell sur-
face modulation of CD107a (LAMP-1). LCMV gp33-spe-
cific CD8
 
 
 
 T cells were identified by tetramer staining (Fig.
1). Effector and memory cells exhibited the same degranula-
tion kinetics; degranulation was detectable after 30 min of
peptide stimulation and increased up to 4 h after stimulation.
IFN
 
 
 
 synthesis was slower than degranulation and required
2 h of peptide stimulation. Similar kinetics of degranulation
and IFN
 
 
 
 production have been reported for human T cell
responses (17). Naive P14 tg CD8
 
 
 
 T cells neither expressed
cell surface CD107 nor intracellular IFN
 
 
 
 within 6 h of pep-
tide stimulation (not depicted).
Next, we analyzed whether antigen-induced cell surface
modulation of CD107 was exclusively observed in CD8
 
 
 
T cells or also in CD4
 
 
 
 T cells. Therefore, we stimulated
naive TCR tg CD4
 
 
 
 T cells (Smarta tg), CD4
 
 
 
 T cells
from acutely infected C57BL/6 mice, or from memory
mice with the MHC class II–restricted gp64 peptide and
analyzed CD107 and IFN
 
 
 
 expression up to 6 h after stim-
ulation. Naive Smarta tg CD4
 
 
 
 T cells neither expressed
CD107 nor IFN
 
 
 
 and acute and memory gp64-specific
CD4
 
 
 
 T cells expressed IFN
 
 
 
 but little if any CD107 (not
depicted). Hence, for LCMV-specific T cells, antigen-induced
abundant surface expression of CD107 is a specific feature
of CD8
 
 
 
 T cells.
 
Degranulation of LCMV-specific CD8
 
 
 
 T Cells Is Not Nec-
essarily Correlated with Cytotoxic Activity.
 
Because effector
and memory cells degranulated with similar kinetics, we
compared the cytotoxic potential of effector and memory
(day 50 after infection) cells in 
 
51
 
Cr release assays (Fig. 2).
As expected, effector CD8
 
 
 
 T cells exhibited stronger cy-
tolytic potential as compared with memory CD8
 
 
 
 T cells.
This discrepancy between degranulation and lytic effector
function could be related to differences in lytic granule
Figure 1. Kinetics of cell surface expression of CD107 and production of intracellular IFN . Spleen cells of acutely infected mice (“Effector,” day
8 after i.v. infection with 200 pfu LCMV WE) or memory mice (50 d after i.v. infection with 200 pfu LCMV WE) were incubated with 1  g/ml gp33
peptide. At the indicated time points, surface expression of CD107a and the intracellular content of IFN  was analyzed by flow cytometry. Plots are
gated on CD8  gp33 tetramer  T cells. One representative staining of at least six different experiments is shown.
Figure 2. Kinetics of cytotoxic activity of effector and
memory gp33-specific T cells. Cytotoxic activity of spleen
effector and memory CD8  T cells was analyzed by 51Cr
release assay. EL4 cells, pulsed with gp33 peptide or unpulsed,
were used as target cells. Specific lysis was determined at
the indicated time points of incubation. E/T ratios indicate
the ratio between gp33 tetramer positive T cells and target
cells. One of four similar experiments is shown. 
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content. Therefore, we analyzed the kinetics of degranula-
tion by staining for CD107 in context with intracellular
grB expression in memory, effector, and naive CD8
 
 
 
T cells (Fig. 3). Effector CD8
 
 
 
 T cells contained sub-
stantial amounts of intracellularly stored grB (66 
 
 
 
 5% of
CD8
 
 
 
tet
 
 
 
 cells). Activation of effector CD8
 
 
 
 T cells in-
duced degranulation, as identified by surface CD107 stain-
ing that coincided with loss of grB staining, indicating that
effector CD8
 
 
 
 T cells released cytotoxic effector molecules
immediately upon antigen encounter (Fig. 3 B). In similar
experiments conducted with human CD8
 
 
 
 T cells, degran-
ulation could also be correlated with loss of intracellularly
stored grB and in addition to loss of perforin (17).
In contrast to effector CD8
 
 
 
 T cells, memory CD8
 
 
 
 T
cells showed only marginal staining for grB, which ex-
plained (despite rapid degranulation) the insufficient cy-
tolytic effector function upon antigen encounter. Naive P14
tg CD8
 
 
 
 T cells neither degranulated nor contained intra-
cellular grB. Interestingly, after 5 h of stimulation, effector
and memory gp33-specific CD8
 
 
 
 T cells showed a signifi-
cant increase in grB content, particularly in cells that co-
stained for CD107. This suggested that both effector and
memory CD8
 
 
 
 T cells began de novo synthesis of grB after
antigen stimulation. To address this hypothesis, effector and
memory (d50) CD8
 
 
 
 T cells were stimulated in the pres-
ence of the protein synthesis inhibitor cyclohexamide
(CHX), and the kinetics of degranulation, grB staining, and
IFN
 
 
 
 production were analyzed (Fig. 4). Cell surface ex-
pression of CD107 was not significantly affected by the
presence of CHX, indicating that cell surface expression of
CD107 originated from translocated CD107 molecules
rather than from newly synthesized molecules. In the pres-
ence of CHX, no IFN
 
 
 
 synthesis was observed in stimu-
lated effector and memory CD8
 
 
 
 T cells. CD107 positive
cells stained negative for grB for the first 2 h after activation,
indicating the release of stored grB. However, at 4 and 6 h
after stimulation, gp33-specific effector and memory CD8
 
 
 
T cells showed a significant increase in grB staining in the
absence of CHX, whereas only a reduced increase in grB
staining was observed in the presence of CHX (Fig. 4).
These data show that degranulation initially releases
stored effector molecules that differ in quantity between ef-
Figure 3. Kinetics degranula-
tion and grB content of naive,
effector, and memory gp33-
specific T cells. (A) Spleen cells
from memory (d50), acutely in-
fected, or naive P14 transgenic
mice were stimulated with 1
 g/ml gp33 peptide. At the in-
dicated time points, cell surface
expression of CD107a and in-
tracellular grB content was ana-
lyzed by flow cytometry. Plots
are gated on CD8  gp33
tetramer  T cells. One of three
similar experiments is shown.
(B) Acquisition of cell surface
CD107 and changes in grB con-
tent in stimulated effector
CD8  T cells. The plots 1–4
show the percentage of CD8 
tet  T cells present in the four
quadrants (1, CD107 grB ; 2,
CD107 grB ; 3, CD107 grB ;
and 4, CD107 grB ) after dif-
ferent time points of stimulation.Wolint et al. 929
fector and memory CD8  T cells, but that de novo synthe-
sis of effector molecules occurs after 4–6 h of antigen stim-
ulation, allowing lytic granules to refill. These results are in
agreement with previous findings that TCR engagement
induced refilling of lytic granules in antigen-experienced
CD8  T cells (23).
Degranulation Occurs with Similar Kinetics in Effector and
Central Memory Cells and Is Temporarily Linked to Down-
Regulation of CD62L in Central Memory Cells. We had ob-
served that memory cells expressing CD107 after activation
were always CD62L negative (unpublished data). There-
fore, we examined whether acquisition of CD107 was
linked to down-regulation of the LN homing marker
CD62L. CD62L positive and negative cells were sorted
from the spleens of LCMV immune memory mice (day 50)
and separately stimulated in vitro. Surface expression of
CD107 and CD62L was analyzed over an observation pe-
riod of 6 h (Fig. 5 A). Within 30 min, a substantial propor-
tion of the LCMV gp33-specific CD8  T cells expressed
CD107 and this proportion increased over the first 2 h of
observation. Acquisition of CD107 (i.e., degranulation) in
sorted CD62L positive central memory T cells was associ-
ated with down-modulation of cell surface CD62L. This
showed that activation leads to degranulation and to down-
modulation of LN homing markers on the cell surface of
CD8  T cells and, thus, to a transition from central mem-
ory to effector memory cells. Similar results were obtained
with memory mice up to 250 d after infection.
The ability of effector memory T cells to infiltrate in-
flamed peripheral tissue is dependent on the expression of
adhesion molecules such as integrins and selectins. The in-
tegrin  4 1 (VLA-4; CD49dCD29) binds to fibronectin,
VCAM-1, and MadCAM-1 and is one of the principal sur-
face proteins that mediate homing of lymphocytes to endo-
thelium at peripheral sites of inflammation (24, 25). There-
fore, we analyzed the expression of CD49d, the integrin  4
chain, on the surface of d50 unstimulated and stimulated
central memory LCMV-specific CD8  T cells (Fig. 5 B).
Interestingly, unstimulated as well as stimulated CD62L 
gp33 tetramer  CD8  T cells expressed CD49d. Similar
results were obtained for central memory cells up to day
250 after infection.
To further address the question whether cell surface up-
regulation of CD107 results from relocalization of intracel-
lularly present CD107, we compared cell surface with in-
tracellular CD107 staining in central and effector memory
CD8  T cells and in effector CD8  T cells before antigen
stimulation (Fig. 5 C). Although no CD107 expression was
detected on the cell surface, a strong staining for CD107
was observed intracellularly, supporting the notion that cell
surface expression of CD107 after activation occurs by
CD107 relocalization from intracellular lytic granules to
the plasma membrane.
CD62L Positive Central Memory Cells Are Less Cytolytic
than CD62L Negative Effector Memory T Cells Due to the Lack
of Cytolytic Effector Molecules. Next, we analyzed the ki-
netics of degranulation, immediate cytolytic effector func-
tion and cytokine production of LCMV-specific central
and effector memory CD8  T cells. Our results demon-
strate that LCMV-gp33–specific central end effector mem-
ory CD8  T cells have similar kinetics of CD107 up-regu-
lation and IFN  production (Fig. 6 A). However, sorted
CD62L negative but not CD62L positive cells were able to
exert low level of immediate cytotoxicity in a 6-h 51Cr re-
lease assay when equivalent numbers of gp33 tetramer pos-
itive central and effector memory cells were used (Fig. 6
B). Consistent with this result, we observed more intracel-
lularly stored grB in effector memory T cells than in central
memory T cells (Fig. 6 B).
Next, we analyzed the grB content in d8 effector CD8 
T cells and in memory CD8  T cell subsets at different
time points after infection (Fig. 6 C). Although  60% ef-
Figure 4. Cell surface expression of CD107a, intracellular IFN  production, and grB content was analyzed at the indicated time points in effector and
memory (d50) gp33-specific CD8  T cells in the presence or absence of CHX. Plots are gated on CD8  gp33 tetramer  T cells. One of two equivalent
experiments is shown.Different Immediate Effector Functions of Virus-specific CD8  T Cell Subsets 930
fector T cells expressed grB, fewer memory cells expressed
grB before stimulation. The overall percentage of grB-
expressing memory cells decreased with time after infection;
however, at all time points analyzed, more grB-expressing
effector memory CD8  T cells were observed than grB-
expressing central memory T cells.
Thus, although central and effector memory T cells
produce cytokines and degranulate with identical kinetics,
Figure 5. Degranulation and surface
expression of CD62L and CD49d of
central and effector gp33-specific memory
T cells. (A) CD62L positive and CD62L
negative cells were sorted from the
spleen of LCMV memory mice (day 50)
and stimulated with 1  g/ml gp33 pep-
tide. After the indicated time points, cell
surface expression of CD107a and
CD62L was analyzed by flow cytometry.
Plots are gated on CD8  gp33
tetramer  T cells. One of three similar
experiments is shown. (B) CD62L posi-
tive and CD62L negative cells were
sorted from the spleen of LCMV mem-
ory mice (day 50) and stimulated with
1  g/ml gp33 peptide. After the indi-
cated time points, cell surface expression
of CD107a and CD49d was analyzed by
flow cytometry. Plots are either gated
on CD8  gp33 tetramer  T cells or on
CD8  T cells. One of three similar
experiments is shown. (C) Cell surface
versus intracellular staining of CD107a.
CD62L positive and CD62L negative
cells were sorted from the spleen of
LCMV memory mice (day 50). Sorted
memory cells and day 8 effector cells were
stained extracellularly or intracellularly
for CD107a. Plots are gated on CD8  T
cells. One of two similar experiments is
shown.Wolint et al. 931
Figure 6. Kinetics of degranulation, IFN 
production, and cytotoxicity of gp33-specific
central and effector memory T cells. (A) Tetramer
staining, cell surface CD107a expression, and
intracellular IFN  production was analyzed at
the indicated time points in sorted CD62L posi-
tive  and negative cells from LCMV memory
mice (day 50). The top row shows staining of
CD62L  T cells (day 50) for CD8 and gp33
tetramer after the indicated time points of stim-
ulation. The two bottom rows show staining
for cell surface CD107 and intracellular IFN .
Plots are gated on CD8  gp33 tetramer  T
cells. One of three similar experiments is
shown. (B) Cytotoxic activity of sorted CD62L
positive and CD62L negative spleen cells of
memory mice (day 50) was analyzed by 51Cr
release assay. EL4 cells, pulsed with gp33 peptide
or unpulsed were used as target cells. Specific
lysis was determined at the indicated time
points of incubation. E/T ratios indicate the
ratio between gp33 tetramer positive T cells
and target cells. The graphs on the right side
show the percentage of grB CD107  and
CD107a  cells of CD8 tet  T cells at the indi-
cated time points after stimulation. One of three
similar experiments is shown. (C) Percentage of
grB  cells of CD8  tet  cells. grB positive cells
were quantified before antigen stimulation
amongst CD8 tet  T cells of d8 effector mice,
of memory mice (days 35 and 50), of sorted
CD62L  and CD62L  memory cells (days 30,
50, and 115), and of naive TCR transgenic
mice.Different Immediate Effector Functions of Virus-specific CD8  T Cell Subsets 932
only effector memory T cells exhibited immediate cy-
tolytic activity.
In Vivo Cytotoxicity Is Reduced in LN Compared With
Blood and Spleen In Memory Mice. Our results showed that
activation of CD62L positive central memory CD8  T
cells resulted in rapid degranulation with concordant
down-modulation of cell surface CD62L. Therefore, acti-
vated central memory cells might emigrate from the LN,
their preferential localization site, and migrate to peripheral
tissues before they acquire cytolytic potential. This would
implicate a reduced immediate cytolytic activity against an-
tigen-presenting cells within the LN. To test this hypothe-
sis, we transfused gp33 peptide-loaded and unloaded anti-
gen-presenting cells into acutely LCMV-infected recipients
(d8 effector mice) or in LCMV memory mice. The target
cell populations were uniformly labeled with PKH-26 and
with two different concentrations of CFSE to differentiate
between peptide-loaded and unloaded target cells. At sev-
eral time points after transfer, specific elimination of gp33-
loaded target cells was assessed in the blood, in the spleen
and the LN. Acutely infected mice were faster and more
efficient in specific target cell elimination measured in the
blood as compared with memory mice (Fig. 7 A), as has
been shown previously (26). For example, by 1 h after
transfer of target cells, acutely infected mice had eliminated
almost 30% of gp33-loaded target cells, whereas memory
mice had eliminated  5%. Because the frequencies of gp33
tetramer positive CD8  T cells were 2–3 times higher in
effector compared with memory mice, this difference rep-
resents at least one reason for faster and more efficient in
vivo elimination of antigen-presenting cells.
In acutely infected mice, specific target elimination in
blood and spleen was comparable at 2 and 6 h after target
cell transfer (Fig. 7 B), whereas it was slower and less
prominent in the LN. In LCMV memory mice, specific
target cell elimination was most prominent in the blood
but completely absent in the LN. This reduced killing in
the LN of effector mice and in particular the absence of
specific killing in the LN of memory mice could partially
be accounted for by the relatively lower frequencies of
tetramer  CD8  T cells in the LN compared with blood
and spleen (Fig. 7 B, numbers above bars). However, this
difference was maximally 1.5–3-fold. Alternative explana-
tions for the reduced killing in LN could be a low E/T ra-
tio. We calculated the effector (gp33 tetramer positive lym-
phocytes)-to-target ratios in the different organs (Fig. 7 C);
the E/T ratios in the LN were always higher compared
with spleen.
Figure 7. In vivo cytotoxicity of acutely LCMV-infected mice and memory mice. (A) gp33 peptide–loaded and unloaded target cells were adoptively
transferred into acutely infected or memory recipient mice. Percentage of specific target cell elimination was analyzed in the blood at the indicated time
points. (B) Specific target cell elimination was quantified in blood, spleen, and LN at 2 and 6 h after adoptive transfer of target cells. Numbers indicate the
percentage of gp33 tetramer positive lymphocytes in the respective organs. (C) E/T ratio in blood, spleen, and LN at 2 and 6 h after adoptive transfer of
target cells. Effector cells were gp33 tetramer positive lymphocytes. (D) Percentage of CD8 gp33 tetramer CD62L  cells in blood, spleen, and LN at 2
and 6 h after adoptive transfer of target cells. One of two similar experiments is shown.Wolint et al. 933
In memory mice, the percentage of gp33-specific T cells
that were CD62L negative (i.e., effector or effector memory
T cells) in blood, spleen, and LN (Fig. 7 D) correlated best
with the observed pattern of specific killing in vivo, suggest-
ing that the predominantly CD62L positive gp33-specific
CD8  T cells in the LN of memory mice were performing
worst with respect to immediate cytolytic activity.
To experimentally address this hypothesis, we adoptively
transfused equal numbers of gp33 tetramer positive purified
central and effector memory cells (Fig. 8 A) into separate
naive recipient animals, followed by transfer of equal num-
bers of gp33-labeled and unlabeled target cells. Specific tar-
get cell elimination was analyzed 4 h after target cell trans-
fer (Fig. 8 B). Indeed, we observed that CD62L negative
effector memory cells exhibited higher levels of specific
killing compared with CD62L positive central memory
cells (Fig. 8 C). These in vivo results corroborate the in
vitro findings that CD62L negative effector memory cells
show higher levels of immediate cytotoxicity as compared
with central memory cells (Fig. 6 B).
Discussion
In this paper, we analyze the kinetics of antigen-induced
degranulation, cytotoxic activity, and effector protein pro-
duction in defined populations of LCMV-specific CD8  T
cells. We compare naive TCR tg CD8  T cells, effector
CD8  T cells, and central and effector memory CD8  T
cells originating from LCMV-infected mice. Degranulation
was analyzed using a novel flow cytometry–based assay that
measures the appearance of lytic granule–associated markers
on the plasma membrane (17). LCMV-specific effector and
memory CD8  T cells degranulated with identical kinetics
upon antigen contact. However, only effector T cells
showed strong cytolytic activity measured by 51Cr release
assays that was associated with the release of stored cyto-
toxic effector molecules. Memory CD8  T cells had only
marginal amounts of stored effector molecules, resulting in
low level immediate cytotoxic activity. Both effector and
memory CD8  T cells initiated de novo synthesis of grB
4–6 h after antigen contact, whereas de novo synthesis of
IFN  was already measurable at 2 h after antigen encoun-
ter. It has been shown that IFN  and perforin mRNA is
present at equivalent levels in effector and memory CD8 
T cells (3, 27) and that regulated on activation, normal T
cell expressed, and secreted (RANTES) mRNA is present
in memory CD8  T cells (28), indicating that regulation of
cytokine, chemokine, and cytolytic effector molecule ex-
pression occurred at the translational level. In contrast, na-
ive LCMV-specific CD8  T cells neither degranulated nor
produced cytokines or cytolytic molecules within 20 h of
antigen stimulation (unpublished data). These findings in-
dicate that a program for immediate degranulation is a fea-
ture of antigen-experienced CD8  T cells that is not yet
functional in naive CD8  T cells, and that regulation of cy-
tolytic activity occurs at the effector protein level. Hence,
degranulation is necessary but not sufficient for perfor-
mance of cytolytic activity.
Two subsets of memory CD8  T cells can be distin-
guished by their recirculation pattern and accordingly by
the expression of LN homing markers such as CD62L,
termed central and effector memory cells (5, 6). These
memory CD8  T cell subsets have been ascribed different
levels of immediate effector functions (5, 7). However,
more recent studies question this differential effector func-
tion (4, 8, 9) and propose that effector memory CD8  T
cells are a transitory population between effector cells and
central memory cells (4, 27, 29). We observed that central
and effector memory CD8  T cells degranulated and pro-
duced IFN  with similar kinetics after antigen contact, in-
Figure 8. In vivo cytotoxicity of adoptively transfused gp33-specific
central and effector memory cells. (A) CD62L positive and negative CD8
T cells were purified from d35 LCMV memory mice. (left) gp33 tetramer
staining: numbers indicate the percentage of CD8  tet  T cells. (right)
CD62L expression on tetramer-gated CD8  T cells. (B) Target cell numbers
in LN 4 h after transfer. 3   105 CD62L positive or CD62L negative
CD8 tet  T cells were transferred into naive recipient mice followed by
transfer of 5   106 gp33-pulsed and mock-pulsed CFSE/PKH26 stained
target cells 3 h later. CFSElow cells were pulsed with gp33 peptide and
CFSEhigh cells were mock pulsed. 4 h after target cell transfer, the ratio of
CFSElow/high target cells was analyzed in the LN. One representative staining
of each group is shown. Cells are gated on PKH26 postive cells. Numbers
indicate the percentage of specific target cell elimination. (C) Specific target
cell elimination (a) 4 h after target cell transfer into recipients having been
transfused with equal numbers of CD62L positive of CD62L negative
LCMV memory T cells. (b) Percentage of CD8  tet  T cells 4 h after target
cell transfer. (c) Percentage of PKH26  target cells 4 h after target cell
transfer. (d) E/T ratio (E   percentage of tetramer  lymphocytes; T  
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dicating that these functions were not restricted to effector
CD8  T cells. However, a significant number effector
memory CD8  T cells contained stored grB that could be
released upon antigen encounter, leading to low levels of
immediate cytotoxicity. In contrast, only very low numbers
of central effector cells had intracellularly stored grB, and as
a result, were incapable of immediate cytolytic activity.
However, the overall percentage of grB-expressing effector
memory cells decreased with time after LCMV infection,
suggesting that grB expression in effector memory CD8  T
cells might be related to relatively recent antigen exposure.
Thus, central memory and effector memory CD8  T cells
differ at the functional level primarily in their expression of
cytolytic effector molecules, and not in their inherent abil-
ity to degranulate in response to stimulation. These data es-
tablish a clear difference in immediate cytolytic effector
function of central and effector memory T cells, which is in
contrast to some papers that did not find any differences in
cytolytic potential of central and effector CTL (4, 8). A po-
tential explanation for this difference could be use of TCR
transgenic CD8  T cells in these analyses as opposed to en-
dogenous polyclonal CD8  T cells in the present paper; the
adoptive transfer of higher numbers of central and effector
memory CD8  T cells for in vivo killing experiments (26);
or the discrimination of effector and central memory CD8 
T cells by CCR7 expression (8) as opposed to CD62L ex-
pression in the present paper.
The difference of immediate in vitro cytolytic activity
between central and effector memory CD8  T cells might
have important in vivo implications with regards to the ef-
ficiency of target cell eliminations in different tissues. These
in vitro observations led to the hypothesis that central
memory CD8  T cells residing in LNs, when activated by
cognate antigen, would degranulate but not exert immedi-
ate effector function due to lack of stored cytolytic effector
molecules. Concomitant down-regulation of CD62L and
expression of tissue homing markers, such as CD49d, com-
bined with delayed de novo synthesis of cytolytic effector
molecules might result in the emigration of restimulated
CD8  T cells from the LN before acquisition of cytolytic
effector function, thus avoiding the immediate destruction
of the restimulating antigen-presenting cells in the LNs.
Analysis of in vivo cytotoxicity (26, 30, 31) in different or-
gans showed that specific target cell elimination was more
pronounced in acutely infected mice than in memory
mice. We observed in acutely infected mice that specific
target cell elimination was comparable in blood and spleen
(in agreement with reference 26), but delayed in LN. In
contrast, we did not observe any specific target cell elimi-
nation in the LN of memory mice within 6 h, whereas the
same mice eliminated target cells from the spleen and
blood. Several potential explanations could account for this
observation as follows. First, relatively lower numbers of
gp33-specific CD8  T cells in LN as compared with blood
and spleen. The frequency of gp33-specific CD8  T cells
was  50% in LN compared with spleen, and this reduced
percentage might partly be responsible for the delayed/ab-
sent killing in the LN. Second, lower E/T ratios were in
LN compared with spleen and blood. This explanation was
refuted by the finding that E/T ratios were higher in LN
than in spleen and comparable to blood. Third, there was
reduced cytotoxic potential of predominantly gp33-specific
central memory T cells in the LN. This possibility seemed
likely because 70% of gp33-specific CD8  T cells were
central memory cells in the LN as opposed to blood and
spleen, where 70–80% of gp33-specific CD8  T cells were
effector memory cells. Fourth, the LN environment could
influence the target cell killing. It has been shown that DC
target cell elimination in the LN of memory mice occurs
relatively slowly compared with acutely primed mice (32);
however, in this work, target cell killing was analyzed only
in LN, therefore precluding a comparison between differ-
ent tissues. Furthermore, it has been shown that DCs are
partially resistant to CD8  T cell–induced apoptosis due to
expression of serpine protease inhibitor 6 (33, 34); how-
ever, we have not analyzed whether upon adoptive transfer
the target cells present in the LN contained a higher per-
centage of DCs as compared with blood and LN. The fact
that target cell killing occurred in the LN of acutely in-
fected mice would argue for the ability of effector cells to
perform cytotoxicity in the LN environment.
To directly assess the hypothesis that effector and central
memory cells differ in their immediate cytolytic potential
in vivo, we transfused equal numbers of gp33-specific puri-
fied central and effector memory CD8  T cells in naive re-
cipients and measured their ability to eliminate gp33-
loaded target cells in vivo. In agreement with our in vitro
findings, we observed that effector memory CD8  T cells
showed enhanced immediate in vivo cytolytic potential as
compared with central memory cells with the same speci-
Table I. Features of Naive, Effector, and Central and Effector Memory CD8  T Cells
Degranulation
program
Effector molecules
stored in granules
Cytotoxicity
(4–6 h)
De novo
synthesis of effector 
molecules (5 h)
IFN  synthesis
(2–4 h)
Naive        
Effector                   
Effector memory              
Central memory              Wolint et al. 935
ficity. This is in contrast with a recent work showing no in
vivo difference in cytolytic potential between LCMV-spe-
cific effector and central memory cells (26). Potential ex-
planations for this discrepancy could be the time point after
infection used for the isolation of memory cells, the viral
strain and the dose used for infection, the numbers of
adoptively transfused memory cells, the compartment in
which target cell elimination is assessed, and the use of
TCR transgenic CD8  T cells as opposed to endogenous
polyclonal CD8  T cells.
In summary (Table I), our data show that immediate de-
granulation upon antigen encounter is a feature of antigen-
experienced but not of naive CD8  T cells. Degranulation
of effector and memory CD8  T cells occurred with simi-
lar kinetics and is not necessarily correlated with immediate
cytolytic activity. Immediate cytotoxic activity is depen-
dent on the presence of stored cytotoxic effector molecules
in lytic granules. Central and effector memory CD8  T
cells degranulated and produced IFN  with identical kinet-
ics. Effector memory cells as opposed to central memory
cells contained small amounts of stored cytotoxic effectors
that mediated low level immediate cytotoxicity. This is re-
flected in vivo by the observation that immediate target cell
killing was not detectable in LNs of memory mice contain-
ing predominantly central memory T cells, but apparent in
spleen and blood, suggesting that this might be a mecha-
nism preventing rapid elimination of restimulating antigen-
presenting cells in the LN.
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